Summary: CRWE Select
A CRWE Financial Publication Company
LOS ANGELES, May 31, 2012 — WallStreet Research™, a leading
independent analyst research firm focusing on the small and
micro-cap marketplace, announced that it will hold The Southern
California Investment Forum (SCIF) Friday, June 1, 2012 at the
Pacific Club in Newport Beach, CA. The event will present selected
emerging companies to an
[Read the Rest...]Date Published: May 31, 2012 - 10:46 am
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) will be presenting at
the Jefferies 2012 Global Healthcare Conference on Tuesday, June 5
at 1:30 p.m. ET/10:30 a.m. PT in New York and at the Goldman Sachs
33rd Annual Global Healthcare Conference on Wednesday, June 6 at
2:20 p.m. ET/11:20 a.m. PT in Rancho Palos Verdes, California. Mark
G. Foletta,
[Read the Rest...]Date Published: May 31, 2012 - 8:00 am
Euro setup is unsustainable, ECB chief warns , Oil near $88 amid
European financial turmoil , and Movado 1Q net income soars as
sales improve ! CRWESelect.com tracks stocks daily and is pleased
to offer its stock watch highlights. Investors can register to
receive FREE Stock Watch Highlights by giving us your e-mail
address in the
[Read the Rest...]Date Published: May 31, 2012 - 6:00 am
Crown Equity Holdings Inc. (CRWE.OB) CRWE Tube, a video sharing
site of CRWE, allows billions of people around the world to upload,
watch and share original videos. With online videos continuing to
experience explosive, viral growth and the web rapidly moving from
text to video, businesses will need to adapt to the shift in video
distribution
[Read the Rest...]Date Published: May 30, 2012 - 8:13 am
Integrated control and safety systems will help BP manage
operations of two new platforms for the Clair Ridge project AUSTIN,
Texas–(CRWENewswire)–BP has awarded Emerson Process Management, a
global business of Emerson (NYSE:EMR), a $23 million contract to
supply control and safety systems for two new offshore oil
platforms in the North Sea. The platforms are part
[Read the Rest...]Date Published: May 30, 2012 - 7:35 am
Animal and in vitro studies show INNO-206 produced anti-multiple
myeloma effects with less toxicity than doxorubicin Study conducted
under the direction of Dr. James R. Berenson at the Institute for
Myeloma & Bone Center Research LOS ANGELES–(CRWENewswire)–CytRx
Corporation (Nasdaq:CYTR), a biopharmaceutical company specializing
in oncology, today announced that in animal and in vitro studies,
its tumor-targeting doxorubicin
[Read the Rest...]Date Published: May 29, 2012 - 5:12 pm
Quiterian, leading European developer of advanced and predictive
analytics software for business and non-technical users, reported
its partnership with Wipro Technologies, the Global Information
Technology, Consulting and Outsourcing Business of Wipro Limited
(NYSE:WIT) to offer advanced customer analytics solutions to
clients across the globe. Wipro Technologies, the global IT
business of Wipro Limited, is a leading
[Read the Rest...]Date Published: May 29, 2012 - 8:00 am
KEMET Corporation (NYSE: KEM), a leading manufacturer of tantalum,
multilayer ceramic, solid aluminum, plastic film, paper and
electrolytic capacitors, reported that it will be presenting at the
KeyBanc Capital Markets Industrial, Automotive & Transportation
Conference in Boston, Massachusetts, on May 31, 2012 at 9:00 AM
EDT. KEMET’s common stock is listed on the NYSE under the
[Read the Rest...]Date Published: May 28, 2012 - 8:05 am
TORONTO, May 25, 2012 (CRWENewswire) — SunOpta Inc. (”SunOpta” or
the “Company”) (Nasdaq:STKL) (TSX:SOY) today announced that it has
signed a definitive agreement to sell its Canadian natural health
products distribution business (operated as Purity Life Natural
Health Products) to an affiliate of Banyan Capital Partners
(”Banyan”). The transaction, valued at CDN $14,700,000, before
transaction
[Read the Rest...]Date Published: May 27, 2012 - 7:30 pm
SAN DIEGO, May 25, 2012 (CRWENewswire) — Apricus Biosciences, Inc.
(”Apricus Bio” or the “Company”) (Nasdaq:APRI)
(http://www.apricusbio.com) announced today that the Canadian
Intellectual Property Office issued a Notice of Allowance for a
Canadian patent on certain methods of manufacture for the Company’s
platform NexACT(R) drug delivery technology. Specifically, the
patent covers the synthesis of Dodecyl 2-(N,
[Read the Rest...]Date Published: May 27, 2012 - 7:10 pm